IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) Price/FCF Ratio: 11.84

Is IQVIA Holdings Inc.’s Price/FCF ratio high or low?

IQVIA Holdings Inc.'s Price/FCF ratio of 11.84 is 44% below its 5-year average of 21.31, near the low end of its 5-year range (10.29–34.19).

The Price/FCF ratio for IQVIA Holdings Inc. (IQV) is 11.84. It is below its 12-month average by 15.26% (13.97).

IQV Price/FCF Ratio Chart

IQV Price/FCF Ratio
11.84-6.33% 1Y
Zoom

IQV Average Price/FCF Ratio Chart

IQV Current vs Average Price/FCF Ratio Chart

IQV Price/FCF Ratio Metrics

PRICE/FCF RATIO

11.84

PRICE/FCF RATIO AVG TTM

13.97

PRICE/FCF RATIO AVG 3Y

20.38

PRICE/FCF RATIO AVG 5Y

21.31

PRICE/FCF RATIO AVG 10Y

26.33

PRICE/FCF RATIO AVG 15Y

25.92

PRICE/FCF RATIO AVG 20Y

25.92

CURRENT VS TTM AVG

-15.26%

CURRENT VS 3Y AVG

-41.91%

CURRENT VS 5Y AVG

-44.44%

CURRENT VS 10Y AVG

-55.04%

CURRENT VS 15Y AVG

-54.32%

CURRENT VS 20Y AVG

-54.32%

IQV Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
IQVIA Holdings Inc. (IQV)11.8413.9720.3821.31
DexCom, Inc. (DXCM)$30.17B21.5336.2664.16176.85
Centene Corporation (CNC)$32.69B5.178.7229.2721.22
Biogen Inc. (BIIB)$29.39B11.2611.0618.7618.56
Zoetis Inc. (ZTS)$34.46B16.2625.6139.3245.63
Veeva Systems Inc. (VEEV)$27.37B53.6930.5733.9639.47
Waters Corporation (WAT)$24.19B115.4839.8139.2938.33
Agilent Technologies, Inc. (A)$38.26B30.6333.0028.8432.18
Mettler-Toledo International Inc. (MTD)$23.50B29.7131.2531.1236.02
BioNTech SE (BNTX)$21.87B17.3227.7915.5417.41

Free Cash Flow Valuation

P/FCF Ratio

11.8

FCF Yield

8.45%

IQVIA Holdings Inc. Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IQVIA Holdings Inc. Price/FCF Ratio FAQ

What is the Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The Price/FCF ratio for IQV stock is 11.84.
Is IQVIA Holdings Inc.'s Price/FCF ratio high or low?
IQVIA Holdings Inc.'s Price/FCF ratio of 11.84 is 44% below its 5-year average of 21.31, near the low end of its 5-year range (10.29–34.19).
What is the TTM average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The TTM average Price/FCF ratio for IQV stock is 13.97.
What is the 3Y average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The 3Y average Price/FCF ratio for IQV stock is 20.38.
What is the 5Y average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The 5Y average Price/FCF ratio for IQV stock is 21.31.
What is the 10Y average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The 10Y average Price/FCF ratio for IQV stock is 26.33.
What is the 15Y average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The 15Y average Price/FCF ratio for IQV stock is 25.92.
What is the 20Y average Price/FCF ratio for IQVIA Holdings Inc. (IQV)?
The 20Y average Price/FCF ratio for IQV stock is 25.92.

IQVIA Holdings Inc. Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-0911.84
2026-06-0811.67
2026-06-0511.66
2026-06-0411.88
2026-06-0311.57
2026-06-0211.48
2026-06-0111.87
2026-05-2911.58
2026-05-2811.51
2026-05-2710.52
2026-05-2610.29
2026-05-2210.67
2026-05-2110.68
2026-05-2010.90
2026-05-1911.01
2026-05-1810.98
2026-05-1510.75
2026-05-1410.85
2026-05-1310.95
2026-05-1211.12
2026-05-1111.03
2026-05-0811.36
2026-05-0711.35
2026-05-0611.21
2026-05-0511.21
2026-05-0411.16
2026-05-0110.94
2026-04-3010.98
2026-04-2910.86
2026-04-2811.02
2026-04-2711.36
2026-04-2411.25
2026-04-2311.14
2026-04-2212.14
2026-04-2112.18
2026-04-2012.25
2026-04-1712.23
2026-04-1611.92
2026-04-1512.34
2026-04-1412.15
2026-04-1311.92
2026-04-1011.60
2026-04-0911.71
2026-04-0811.96
2026-04-0711.83
2026-04-0611.83
2026-04-0212.01
2026-04-0111.95
2026-03-3111.82
2026-03-3011.52
2026-03-2711.36
2026-03-2611.74
2026-03-2511.48
2026-03-2411.51
2026-03-2311.57
2026-03-2011.51
2026-03-1911.54
2026-03-1811.58
2026-03-1711.67
2026-03-1611.43
2026-03-1311.42
2026-03-1211.29
2026-03-1111.89
2026-03-1011.85
2026-03-0912.38
2026-03-0612.09
2026-03-0512.37
2026-03-0412.33
2026-03-0312.06
2026-03-0212.08
2026-02-2712.39
2026-02-2611.83
2026-02-2511.22
2026-02-2411.43
2026-02-2311.25
2026-02-2011.48
2026-02-1911.74
2026-02-1811.86
2026-02-1711.40
2026-02-1310.86
2026-02-1210.98
2026-02-1111.52
2026-02-1011.87
2026-02-0912.53
2026-02-0612.19
2026-02-0511.77
2026-02-0413.17
2026-02-0313.25
2026-02-0215.04
2026-01-3014.97
2026-01-2915.32
2026-01-2815.59
2026-01-2715.68
2026-01-2615.57
2026-01-2315.30
2026-01-2215.55
2026-01-2115.70
2026-01-2015.20
2026-01-1615.46
2026-01-1515.69
2026-01-1415.70
2026-01-1315.71
2026-01-1215.67
2026-01-0915.77
2026-01-0815.82
2026-01-0715.89
2026-01-0615.64
2026-01-0515.26
2026-01-0214.66
2025-12-3114.66
2025-12-3014.81
2025-12-2914.77
2025-12-2614.76
2025-12-2414.70
2025-12-2314.64
2025-12-2214.59
2025-12-1914.35
2025-12-1814.47
2025-12-1714.40
2025-12-1614.42
2025-12-1514.54
2025-12-1214.46
2025-12-1114.70
2025-12-1014.50
2025-12-0914.18
2025-12-0814.54
2025-12-0514.69
2025-12-0414.63
2025-12-0314.78
2025-12-0214.67
2025-12-0114.86
2025-11-2814.96
2025-11-2615.08
2025-11-2515.08
2025-11-2414.84
2025-11-2114.63
2025-11-2014.12
2025-11-1914.14
2025-11-1814.13
2025-11-1714.06
2025-11-1414.35
2025-11-1314.54
2025-11-1214.37
2025-11-1114.21
2025-11-1013.86
2025-11-0713.69
2025-11-0613.71
2025-11-0513.67
2025-11-0413.72
2025-11-0313.91
2025-10-3114.08
2025-10-3014.08
2025-10-2914.17
2025-10-2814.19
2025-10-2718.74
2025-10-2419.00
2025-10-2318.95
2025-10-2218.77
2025-10-2118.84
2025-10-2018.27
2025-10-1717.63
2025-10-1617.73
2025-10-1517.50
2025-10-1417.64
2025-10-1317.56
2025-10-1017.08
2025-10-0917.49
2025-10-0817.29
2025-10-0717.31
2025-10-0617.67
2025-10-0317.81
2025-10-0217.61
2025-10-0117.56
2025-09-3016.37
2025-09-2915.57
2025-09-2615.47
2025-09-2515.23
2025-09-2415.62
2025-09-2316.07
2025-09-2216.19
2025-09-1916.13
2025-09-1816.39
2025-09-1716.09
2025-09-1616.10
2025-09-1516.02
2025-09-1216.13
2025-09-1116.43
2025-09-1015.84
2025-09-0916.34
2025-09-0816.17
2025-09-0516.17
2025-09-0415.86
2025-09-0315.91
2025-09-0215.83
2025-08-2916.44
2025-08-2816.26
2025-08-2716.27
2025-08-2616.18
2025-08-2516.20
2025-08-2216.47
2025-08-2115.97
2025-08-2016.55
2025-08-1916.57
2025-08-1816.59
2025-08-1516.47
2025-08-1416.32
2025-08-1316.39
2025-08-1216.02
2025-08-1115.52
2025-08-0815.50
2025-08-0715.42
2025-08-0615.29
2025-08-0515.85
2025-08-0415.75
2025-08-0115.72
2025-07-3116.02
2025-07-3016.50
2025-07-2916.76
2025-07-2817.04
2025-07-2517.16
2025-07-2417.30
2025-07-2316.74
2025-07-2216.15
2025-07-2113.04
2025-07-1813.17
2025-07-1713.39
2025-07-1613.01
2025-07-1512.93
2025-07-1413.13
2025-07-1113.35
2025-07-1013.58
2025-07-0913.29
2025-07-0813.49
2025-07-0713.32
2025-07-0313.47
2025-07-0213.50
2025-07-0113.34
2025-06-3012.92
2025-06-2712.92
2025-06-2612.97
2025-06-2513.02
2025-06-2413.01
2025-06-2312.73
2025-06-2012.69
2025-06-1812.68
2025-06-1712.64
2025-06-1613.06
2025-06-1312.87
2025-06-1213.05
2025-06-1113.03
2025-06-1013.10
2025-06-0912.64
2025-06-0612.49
2025-06-0512.09
2025-06-0412.13
2025-06-0311.71
2025-06-0211.41
2025-05-3011.51
2025-05-2911.57
2025-05-2811.38

Showing the most recent 260 of 3,291 data points. The chart above shows the full history.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib